Explore this week’s CC Journal Club

90-sec video • 4-min audio • paper abstracts

This week, 18 May 2025:

1. Obesity: Tirzepatide reduces weight by 20.2% versus 13.7% with semaglutide at 72 weeks.
2. Narcolepsy type 1: Oveporexton increases mean sleep latency by up to 25.4 minutes and improves ESS scores.
3. Second-line ART in children: TAF-emtricitabine and dolutegravir boost viral suppression at 96 weeks.
4. Porcine kidney xenotransplantation: Immediate graft function without AMR or TMA, patient died of cardiac causes.